Your browser doesn't support javascript.
loading
B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses.
Lin, Ke; Zhou, Yawen; Ai, Jingwen; Wang, Yan A; Zhang, Senxin; Qiu, Chao; Lian, Chaoyang; Gao, Bo; Liu, Tingting; Wang, Hongyu; Zhang, Haocheng; Zhang, Yi; Fu, Zhangfan; Li, Dan; Jiang, Ning; Guo, Jingxin; Wu, Jing; Wang, Yan O; Song, Shusen; Li, Qiang; Yin, Yanan; Xia, Jia; Xu, Yingjie; Yeap, Leng-Siew; Zheng, Xiaoqi; Gu, Ye; Liu, Hongyan; Zhang, Wenhong; Meng, Fei-Long.
Afiliación
  • Lin K; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhou Y; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People's Republic of China.
  • Ai J; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Wang YA; CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Zhang S; Department of Mathematics, Shanghai Normal University, Shanghai, People's Republic of China.
  • Qiu C; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Lian C; Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Gao B; Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Liu T; Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Wang H; State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People's Republic of China.
  • Zhang H; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Zhang Y; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Fu Z; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Li D; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Jiang N; CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Guo J; State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, People's Republic of China.
  • Wu J; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Wang YO; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
  • Song S; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Li Q; CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Yin Y; CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Xia J; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Xu Y; Department of Nephrology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Yeap LS; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Zheng X; Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Gu Y; Department of Mathematics, Shanghai Normal University, Shanghai, People's Republic of China.
  • Liu H; CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Zhang W; CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China.
  • Meng FL; Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People's Republic of China.
Emerg Microbes Infect ; 11(1): 452-464, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35045787
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos